Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Capraro; Hans-Georg
Address:
Rheinfelden, CH
No. of patents:
28
Patents:












Patent Number Title Of Patent Date Issued
8026247 Bicyclic amides as kinase inhibitors September 27, 2011
The invention relates to compounds of formula (I) and their use in the treatment of the animal or human body, to pharmaceutical compositions comprising a compound of formula I and to the use of a compound of formula I for the preparation of pharmaceutical compositions for use in the
7998972 1H-imidazo[4,5-c]quinoline derivatives in the treatment of protein kinase dependent diseases August 16, 2011
The invention relates to the use of imidazoquinolines and salts thereof in the treatment of protein kinase dependent diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases, imidazoquinolines for use in the treatment of protein kinase depend
7390805 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives June 24, 2008
The invention relates to 7H-pyrrolo[2,3-d]pyrimidine derivatives of formula I ##STR00001## wherein the symbols and substituents are as defined in the description, to processes for the preparation thereof, to pharmaceutical compositions comprising such derivatives and to the use of s
7326699 4-Amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3-d)pyrimidine derivatives February 5, 2008
The invention relates to new 4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives, processes for the preparation thereof, the application thereof in a process for the treatment of the human or animal body, the use thereof-alone or in combination with one or more other p
7323469 7H-pyrrolo[2,3-d]pyrimidine derivatives January 29, 2008
The invention relates to 7H-pyrrolo[2,3-d]pyrimidine derivatives of formula I ##STR00001## wherein the symbols and substituents are as defined in the description, to processes for the preparation thereof, to pharmaceutical compositions comprising such derivatives and to the use of s
7244729 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives July 17, 2007
The invention relates to 7H-pyrrolo[2,3-d]pyrimidine derivatives of formula I wherein the symbols and substituents are as defined in the description, to processes for the preparation thereof, to pharmaceutical compositions comprising such derivatives and to the use of such derivative
7091346 Purine derivatives and processes for their preparation August 15, 2006
2-Amino-6-anilino-purine derivatives of the formula 1 ##STR00001## in which the symbols are as defined in claim 1 are described.These compounds inhibit p34.sup.cdc2/cyclin B.sup.cdc13 kinase and can be used for treatment of hyperproliferative diseases, for example tumour diseases.
6767906 2-amino-6-anilino-purines and their use as medicaments July 27, 2004
This application discloses 2-amino-6-anilino-purine derivatives of the formula I ##STR1##in which q is 1-5, and R.sub.1 is .alpha.) --S(.dbd.O).sub.k --NR.sub.6 R.sub.7, in which k is 1 or 2, wherein under the proviso that R.sub.6 and R.sub.7 cannot be simultaneously hyd
6451973 Anilinopeptide derivatives September 17, 2002
The invention relates to compounds of the formula I, ##STR1##in which R.sub.1 and R.sub.2 are, independently of each other, lower alkyl or lower alkoxy-lower alkyl; R.sub.3 and R.sub.4 are, independently of each other, sec-lower alkyl or tert-lower alkyl; R.sub.5 is phenyl or cy
6300519 Antivirally active heterocyclic azahexane derivatives October 9, 2001
There are described compounds of formula I*, ##STR1##whereinR.sub.1 is lower alkoxycarbonyl,R.sub.2 is secondary or tertiary lower alkyl or lower alkylthio-lower alkyl,R.sub.3 is phenyl that is unsubstituted or substituted by one or more lower alkoxy radicals, or C.sub.4 -C.sub.8 cycloal
6225345 Azahexane derivatives as substrate isosters of retroviral asparate proteases May 1, 2001
The invention relates to compounds of formula (I): ##STR1##wherein R.sub.1 and R.sub.10 are each independently of the other lower alkoxycarbonyl; either R.sub.2, R.sub.3 and R.sub.4 are each independently of the other C.sub.1 -C.sub.4 alkyl and R.sub.7, R.sub.8 and R.sub.9 are each s
6166004 Combinations of HIV protease inhibitors with reverse transcriptase inhibitors December 26, 2000
There are described compounds of formula I*, ##STR1## wherein R.sub.1 is lower alkoxycarbonyl,R.sub.2 is secondary or tertiary lower alkyl or lower alkylthio-lower alkyl,R.sub.3 is phenyl that is unsubstituted or substituted by one or more lower alkoxy radicals, or C.sub.4 -C.sub.8 c
6110946 Antivirally active heterocyclic azahexane derivatives August 29, 2000
There are described compounds of formula I*, ##STR1## wherein R.sub.1 is lower alkoxycarbonyl,R.sub.2 is secondary or tertiary lower alkyl or lower alkylthio-lower alkyl,R.sub.3 is phenyl that is unsubstituted or substituted by one or more lower alkoxy radicals, or C.sub.4 -C.sub.8 c
5935976 Antiviral ethers of aspartate protease substrate isosteres August 10, 1999
Antiretroviral compounds (which are effective, for example, against HIV) of the formula I ##STR1## in which R.sub.1 is an acyl radical lower-alkoxy-lower-alkanoyl whose lower alkoxy radical is unsubstituted or is substituted by halogen, phenyl, lower alkoxy or a heterocyclic radi
5912352 Intermediates for the preparation of peptide analogues June 15, 1999
The invention relates to a novel process for the preparation of compounds of formula I ##STR1## wherein R.sub.1 is hydrogen or a suitable amino-protecting group,R.sub.2 is unsubstituted or substituted alkyl,R.sub.3 is hydrogen, aryl, heterocyclyl, unsubstituted or substituted alkyl o
5849911 Antivirally active heterocyclic azahexane derivatives December 15, 1998
There are described compounds of formula I*, ##STR1## wherein R.sub.1 is lower alkoxycarbonyl,R.sub.2 is secondary or tertiary lower alkyl or lower alkylthio-lower alkyl,R.sub.3 is phenyl that is unsubstituted or substituted by one or more lower alkoxy radicals, or C.sub.4 -C.sub.8 c
5807891 Antiviral ethers of aspartate protease substrate isosteres September 15, 1998
Antiretroviral compounds (which are effective, for example, against HIV) of the formula I ##STR1## in which R.sub.1 is an acyl radical lower-alkoxy-lower-alkanoyl whose lower alkoxy radical is unsubstituted or is substituted by halogen, phenyl, lower alkoxy or a heterocyclic radi
5686439 Chelate complexes and processes for their preparation November 11, 1997
Phthalocyanine-chelate complexes of formula I ##STR1## are described which contain as central atom M aluminium, gallium, indium, tin, ruthenium or preferably germanium and in which the remaining symbols are as defined in claim 1. The complexes can be used inter alia in the photod
5670491 Chelate complexes and processes for their preparation September 23, 1997
Phthalocyanine chelate complexes of formula I ##STR1## are described which contain as central atom M aluminum; gallium, indium, tin, ruthenium or preferably germanium and in which the remaining symbols are as defined in claim 1. The complexes can be used inter alia in the photody
5663200 Antiviral ethers of aspartate protease substrate isosteres September 2, 1997
Antiretroviral compounds (which are effective, for example, against HIV) of the formula I ##STR1## in which R.sub.1 is an acyl radical lower-alkoxyl-lower-alkanoyl whose lower alkoxy radical is unsubstituted or is substituted by halogen, phenyl, lower alkoxy or a heterocyclic rad
5643878 5-amino-4-hydroxyhexanoic acid derivatives July 1, 1997
Compounds of formula I ##STR1## or their hydroxy-protected derivatives, and compounds of formula I' ##STR2## wherein T is an acyl radical of formula Z ##STR3## wherein R.sup.z is unsubstituted or substituted hydrocarbyl wherein at least one carbon atom has been replaced b
5376685 Arylhydrazones using as SAMDC inhibitors December 27, 1994
Compounds of formula I ##STR1## wherein A, X.sub.1, X.sub.2, X.sub.3, X.sub.4, Y, Z and R.sub.1 to R.sub.6 have the meanings given in the description, have valuable pharmaceutical properties and are effective especially against tumors. They are prepared in a manner known per se.
5354761 Bipyridyls October 11, 1994
Compounds of formula I ##STR1## wherein Y, Z, S, S', m, n and R.sub.1 -R.sub.4 are as defined in the description, have valuable pharmaceutical properties and are effective especially against protozoal infections. They are prepared in a manner known per se.
5238941 Arylhydrazones and pharmaceutical compositions thereof August 24, 1993
Compounds of formula I ##STR1## wherein A, X.sub.1, X.sub.2, X.sub.3, X.sub.4, Y, Z and R.sub.1 to R.sub.6 have the meanings given in the description, have valuable pharmaceutical properties and are effective especially against tumours. They are prepared in a manner known per se.
5118709 Arylhydrazones and pharmaceutical compositions containing the same June 2, 1992
Compounds of formula I ##STR1## wherein A, X.sub.1, X.sub.2, X.sub.3, X.sub.4, Y, Z and R.sub.1 to R.sub.6 have the meanings given in the description, have valuable pharmaceutical properties and are effective especially against tumours. They are prepared in a manner known per se.
5064832 Biaryl compounds November 12, 1991
Compounds of formula I ##STR1## wherein X.sub.1, X.sub.2, X.sub.3, X.sub.4, X.sub.5, X.sub.6, Y, Z and R.sub.1 -R.sub.4 are as defined in the description, have valuable pharmaceutical properties and are especially active against tumors. They are prepared in a manner known per se.
4971986 Arylhydrazones useful as SAMDC inhibitors November 20, 1990
Compounds of formula I ##STR1## wherein A, X.sub.1, X.sub.2, X.sub.3, X.sub.4, Y, Z and R.sub.1 to R.sub.6 have the meanings given in the description, have valuable pharmaceutical properties and are effective especially against tumors. They are prepared in a manner known per se.
4968804 Bipyridine compounds November 6, 1990
Compounds of formula I ##STR1## wherein X.sub.1, X.sub.2, X.sub.3, X.sub.4, X.sub.5, X.sub.6, Y, Z and R.sub.1 -R.sub.4 are as defined in the description, have valuable pharmaceutical properties and are especially active against tumours. They are prepared in a manner known per se










 
 
  Recently Added Patents
Flashlight
Virtual appliance update method
Cooler
Synergistic preparations based on mixtures of glycerol ether with aromatic alcohol for controlling mycobacteria
Semiconductor device and fabrication method
Water slide
Two dimensional magnetic sensor immune to skew angle misalignment
  Randomly Featured Patents
Therapeutic formulation for administering tolterodine with controlled release
Two-component polyurethane adhesive
Golf swing training method
Method, system, and computer readable medium for ranking and displaying a pool of links identified and aggregated from multiple customer reviews pertaining to an item in an electronic catalog
Multicast path building method and device
Fluid pulsation apparatus
Magneto-optical storage medium having in-plane magnetized layers
Container for the storage and shipment of silicon disks or wafers
Modified structure of a telescopic belt buckle
Illuminated locking tape measure device